Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001193125-26-089111

EVP and Chief Legal Officer sold 8,135 shares at $22.80 ($185,478)

  • EVP and Chief Legal Officer acquired 11,137 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Parschauer Karah Herdman · EVP and Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-01 Grant or award : show line 1 in the form +11,137 84,408 D
2026-03-02 Sale : show line 2 in the form −8,135 $22.80 $185,478 76,346 D
Open-market sales · 8,135 sh · avg $22.80 · $185,478
Loading xslF345X05/ownership.xml…